Related Experiment Video
Updated: May 18, 2026

03:57
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Relationship between parathyroid hormone and depression in heart failure
Hakan Altay1, Ali Zorlu, Halil Tolga Kocum
1Department of Cardiology, Baskent University Faculty of Medicine, Adana, Turkey. sakaltay@yahoo.com
Arquivos Brasileiros De Cardiologia
|September 18, 2012
Summary
Depression in systolic heart failure (HF) patients is linked to higher parathyroid hormone (PTH) levels. This association may explain depression
Area of Science:
- Cardiology
- Endocrinology
- Psychiatry
Background:
- Depression predicts rehospitalization and mortality in heart failure (HF).
- Parathyroid hormone (PTH) is a promising biomarker for HF outcomes.
- Investigating the link between depression and PTH in HF is crucial.
Purpose of the Study:
- To explore the association between depression and serum PTH levels in patients with systolic HF.
- To identify predictors of moderate to severe depression in this population.
Main Methods:
- 100 outpatients with systolic HF (LVEF < 40%) were studied.
- Assessed depression using Beck Depression Inventory-II (BDI).
- Measured serum PTH, brain natriuretic peptide (BNP), and C-reactive protein (CRP).
Main Results:
- 51% of patients had moderate to severe depression (BDI score > 18).
- Higher PTH levels were observed in depressed patients (133 pg/ml vs. 71 pg/ml).
- PTH, LVEF, NYHA class, CRP, and edema independently predicted depression severity.
Conclusions:
- Moderate to severe depression in systolic HF is associated with elevated PTH and CRP levels.
- Poor functional status and lower LVEF are linked to depression in HF.
- These associations may elucidate depression's role in HF hospitalization and mortality.
Related Concept Videos
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...